Sjogren Eric 4
4 · Calithera Biosciences, Inc. · Filed Apr 5, 2018
Insider Transaction Report
Form 4
Sjogren Eric
SR. VP, DRUG DISCOVERY
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-04-03−8,209→ 0 totalExercise: $0.48Exp: 2021-12-13→ Common Stock (8,209 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-04-03−8,601→ 0 totalExercise: $0.48Exp: 2022-06-12→ Common Stock (8,601 underlying) - Exercise/Conversion
Common Stock
2018-04-03$0.48/sh+16,810$8,069→ 42,818 total
Footnotes (3)
- [F1]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan each on May 15, 2015, November 13, 2015, May 13, 2016, June 9, 2017 and December 8, 2017. Includes 1,877 shares acquired under the Company's 2014 Employee Stock Purchase Plan on November 15, 2016.
- [F2]1/48 of the Option vests in equal monthly installments one month from 11/07/2011.
- [F3]1/48 of the Option vests in equal monthly installments one month from 03/27/2012.